Jan 22 (Reuters) – Finnish drug wholesaler Oriola was found to have had shortcomings in the autumn of 2017 which threatened the distribution of pharmaceuticals in Finland, drug safety agency Fimea said in a report obtained by STT news agency on Wednesday.
Oriola, which sells pharmaceuticals to pharmacy stores and hospitals in Finland, did not fulfil the legal requirements required for a drug wholesaler, Fimea said in its inspection report, according to STT.
Fimea and Oriola were not immediately available for comment. (Reporting by Boleslaw Lasocki in Gdansk, editing by Louise Heaven)
Our Standards:The Thomson Reuters Trust Principles.
